These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6463569)

  • 1. Binding of apolipoprotein E-rich remnant lipoproteins to human liver membranes.
    Florén CH
    Scand J Gastroenterol; 1984 Jun; 19(4):473-9. PubMed ID: 6463569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake.
    Mahley RW; Hui DY; Innerarity TL; Beisiegel U
    Arteriosclerosis; 1989; 9(1 Suppl):I14-8. PubMed ID: 2536272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolism of chylomicrons and very low density lipoproteins].
    Windler E
    Klin Wochenschr; 1990; 68 Suppl 22():19-22. PubMed ID: 2087074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice.
    Shimano H; Namba Y; Ohsuga J; Kawamura M; Yamamoto K; Shimada M; Gotoda T; Harada K; Yazaki Y; Yamada N
    J Clin Invest; 1994 May; 93(5):2215-23. PubMed ID: 8182153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic binding of triglyceride-rich lipoproteins in humans.
    Florén CH
    Scand J Clin Lab Invest; 1985 Oct; 45(6):531-7. PubMed ID: 2999965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids.
    Jackson KG; Wolstencroft EJ; Bateman PA; Yaqoob P; Williams CM
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):405-17. PubMed ID: 16935699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of chylomicron remnant binding to rat liver membranes.
    Cooper AD; Erickson SK; Nutik R; Shrewsbury MA
    J Lipid Res; 1982 Jan; 23(1):42-52. PubMed ID: 6799601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and uptake of chylomicron remnants by primary and THP-1 human monocyte-derived macrophages: determination of binding proteins.
    Elsegood CL; Pal S; Roach PD; Mamo JC
    Clin Sci (Lond); 2001 Aug; 101(2):111-9. PubMed ID: 11473484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver.
    Arbeeny CM; Rifici VA
    J Biol Chem; 1984 Aug; 259(15):9662-6. PubMed ID: 6086643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.
    Windler E; Havel RJ
    J Lipid Res; 1985 May; 26(5):556-65. PubMed ID: 4020294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity binding of chylomicron remnants to rat liver plasma membranes.
    Carrella M; Cooper AD
    Proc Natl Acad Sci U S A; 1979 Jan; 76(1):338-42. PubMed ID: 284350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.
    Windler EE; Greeve J; Daerr WH; Greten H
    Biochem J; 1988 Jun; 252(2):553-61. PubMed ID: 3415673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
    Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    Yu KC; Jiang Y; Chen W; Cooper AD
    J Lipid Res; 2000 Nov; 41(11):1715-27. PubMed ID: 11060341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
    Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-mediated mechanisms of lipoprotein remnant catabolism.
    Chappell DA; Medh JD
    Prog Lipid Res; 1998 Dec; 37(6):393-422. PubMed ID: 10209655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the mechanisms of uptake and endocytosis of small and large chylomicron remnants by rat liver.
    Windler E; Greeve J; Robenek H; Rinninger F; Greten H; Jäckle S
    Hepatology; 1996 Aug; 24(2):344-51. PubMed ID: 8690403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.